DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 03 · Volume 87 · 2002 DOI: 10.1055/s-007-35601

Commentary

In Focus

366
Rodriguez, M. H.; Enjolras, N.; Plantier, J. L.; Réa, M.; Leboeuf, M.; Uzan, G.; Bordet, J. C.; Négrier, C.: Expression of Coagulation Factor IX in a Haematopoietic Cell Line
374
Myers, Daniel; Wrobleski, Shirley; Londy, Frank; Fex, Beverly; Hawley, Angela; Schaub, Robert; Greenfield, Lazar; Wakefield, Thomas: New and Effective Treatment of Experimentally Induced Venous Thrombosis with Anti-inflammatory rPSGL-Ig

Review Article

394
Moser, Tammy L.; Stack, M. Sharon; Wahl, Miriam L.; Pizzo, Salvatore V.: The Mechanism of Action of Angiostatin: Can You Teach an Old Dog New Tricks?
431
Poon, Man-Chiu; Lillicrap, David; Hensman, Caroline; Card, Robert; Scully, Mary-Frances; Members of Asso cia tion of Hemophilia Clinic Directors of Canada* and Canadian Association of Nurses in Hemophilia Care*: Recombinant Factor IX Recovery and Inhibitor Safety: A Canadian Post-licensure Surveillance Study
436
Shima, Midori; Matsumoto, Tomoko; Fukuda, Kazuyoshi; Kubota, Youko; Tanaka, Ichiro; Nishiya, Katumi; Giles, Alan R.; Yoshioka, Akira: The Utility of activated Partial Thromboplastin Time (aPTT) Clot Waveform Analysis in the Investigation of Hemophilia A Patients with very Low Levels of Factor VIII Activity (FVIII:C)
442
Barrowcliffe, T.W.; Fábregas, P.; Jardi, M.; Cancelas, J.; Rabaneda, M.; Felez, J.: Procoagulant Activity of T Lymphoblastoid Cells due to Exposure of Negatively Charged Phospholipid
459
Nogami, Keiji; Shima, Midori; Nishiya, Katsumi; Sakurai, Yoshihiko; Tanaka, Ichiro; Giddings, John C.; Saenko, Evgueni L.; Yoshioka, Akira: Human Factor VIII Inhibitor Alloantibodies with a C2 Epitope Inhibit Factor Xa-catalyzed Factor VIII Activation: A new Anti-factor VIII Inhibitory Mechanism
466
Favaloro, Emmanuel J.; Bukuya, Melinda; Martinelli, Teresa; Tzouroutis, Joanne; Duncan, Elizabeth; Welldon, Katie; Collecutt, Margaret; Aumann, Heather; Thom, Jim; Gilmore, Grace: A Comparative Multi-laboratory Assessment of Three Factor VIII/von Willebrand Factor Concentrates
477
Miller, G. J.; Cooke, C. J.; Nanjee, M. N.; Howarth, D. J.; Cooper, J. A.; Stepanova, I. P.; Morrissey, J. H.; Miller, N. E.: Factor VII Activation, Apolipoprotein A-I and Reverse Cholesterol Transport: Possible Relevance for Postprandial Lipaemia
483
Curvers, Joyce; Christella, M.; Thomassen, G. D. L.; de Ronde, Hans; Bertina, Rogier M.; Rosendaal, Frits R.; Tans, Guido; Rosing, Jan: Effects of (Pre-)analytical Variables on Activated Protein C Resistance Determined Via a Thrombin Generation-based Assay
493
Zhang, Lu; Seiffert, Dietmar; Fowler, Bruce J.; Jenkins, George R.; Thinnes, Therese C.; Loskutoff, David J.; Parmer, Robert J.; Miles, Lindsey A.: Plasminogen Has a Broad Extrahepatic Distribution
502
Kolev, Krasimir; Gombás, Judit; Váradi, Balázs; Skopá, Judit; Mede, Katalin; Pitlik, Ervin; Nagy, Zoltán; Machovich, Raymund: Immunoglobulin G from Patients with Antiphospholipid Syndrome Impairs the Fibrin Dissolution with Plasmin
509
518
Espinola, Ricardo G.; Pierangeli, Silvia S.; Ghara, Azzudin E.; Harris, E. Nigel: Hydroxychloroquine Reverses Platelet Activation Induced by Human IgG Antiphospholipid Antibodies
523
Xie, Shaoping; O’Regan, David J.; Kakkar, Vijay V.; Scully, Michael F.: 15 Deoxy Δ12,14 PGJ2 Induces Procoagulant Activity in Cultured Human Endothelial Cells
530
Lijnen, H. R.; Van Hoef, B.; Frederix, L.; Rio, M.-C.; Collen, D.: Adipocyte Hypertrophy in Stromelysin-3 Deficient Mice with Nutritionally Induced Obesity

Letters to the Editor

536
Gris, Jean-Christophe; Balducchi, Jean-Pierre; Quéré, Isabelle; Hoffet, Méderic; Marès, Pierre: Enoxaparin Sodium Improves Pregnancy Outcome in Aspirin-resistant Antiphospholipid/Antiprotein Antibody Syndromes
540
Zawadzki, Christophe; Preudhomme, Claude; Gavériaux, Valérie; Amouyel, Philippe; Jude, Brigitte: The Arg200Trp Mutation in the Human Tissue Factor Gene
541
Srivastava, Alok; Mathews, Vikram; Bhurani, Dinesh; Baidya, Shoma; Chandy, Mammen: Successful Surgical Hemostasis in Patients with von Willebrand Disease following Infusion of Koate®DVI